• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 84 of 100
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
HealthValeant Vows to Make Its Drugs ‘Affordable’
By Laura LorenzettiJanuary 13, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
HealthBiosimilars Are Coming After Big Pharma’s Bottom Line
By Laura LorenzettiJanuary 12, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
HealthDrugmaker Shire Is Buying Baxalta for $32 Billion
By ReutersJanuary 11, 2016
Pfizer In Merger Talks With Allergan PLC
HealthPfizer Just Jacked Up Prices for All of These Drugs
By ReutersJanuary 9, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
HealthShire’s Merger With Baxalta Merger Is Nearly Done
By ReutersJanuary 8, 2016
<> at Downsview Park on September 20, 2015 in Toronto, Canada.
Arts & EntertainmentWu-Tang’s RZA Says He Doesn’t Care What Martin Shkreli Does with His Album
By Laura LorenzettiJanuary 6, 2016
New York Mets v Washington Nationals
Arts & EntertainmentWhy These Baseball Stars Are Suing Al Jazeera
By Michal AddadyJanuary 6, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
HealthValeant Appoints Howard Schiller Interim CEO
By ReutersJanuary 6, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
HealthShire-Baxalta $32 Billion Merger Talks Said to Advance
By Michal AddadyJanuary 3, 2016
US-CRIME-JUSTICE-SHKRELI
HealthMartin Shkreli’s Old Company Has Filed For Bankruptcy
By ReutersDecember 30, 2015
sb10065848dh-001
TechNew Research Shows How the Liver Fights off Sugar Cravings
By Hilary BrueckDecember 29, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
LeadershipValeant Will Be Run by a Group of Executives Until Its CEO Returns
By ReutersDecember 28, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
LeadershipValeant CEO J. Michael Pearson Hospitalized for ‘Severe’ Pneumonia
By ReutersDecember 26, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthAftershocks Keep Coming After Former Pharma CEO’s Arrest
By ReutersDecember 23, 2015
Inside Teva Pharmaceuticals Headquarters
HealthCelgene Settles U.S. Patent Litigation for Revlimid
By Reuters and Aaron TaskDecember 22, 2015
1...
  • 82
  • 83
  • 84
  • 85
  • 86
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Success
Red flag test: former CEO explains why he rejects job candidates who say they can start right awayplaceholder alt text
By Orianna Rosa RoyleMay 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.